Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Anti-Cardiolipin Antibody Kit ELISA

Le kit ELISA Anti-Cardiolipin Antibody (ABIN2648616) Humain est un kit ELISA Colorimetric conçu pour quantifier Humain Anti-Cardiolipin Antibody.
N° du produit ABIN2648616
1.038,13 €
Plus frais de livraison 40,00 € et TVA
96 tests
Destination: France
Envoi sous 10 à 12 jours ouvrables

Aperçu rapide pour Anti-Cardiolipin Antibody Kit ELISA (ABIN2648616)

Antigène

Tous les produits Anti-Cardiolipin Antibody (ACA)
Anti-Cardiolipin Antibody (ACA)

Reactivité

Humain

Méthode de détection

Colorimetric

Application

ELISA

Type d'échantillon

Serum, Plasma
  • Sensibilité

    0.08 AU/ml

    Attributs du produit

    Anti Cardiolipin Screen ELISA Assay Kit allows to determine the unknown concentration of auto-antibodies directed against the Cardiolipin-β2-glycoprotein complex through two different calibration curve (one specific for IgG test, one specific for IgM test), two different conjugates linked to horseradish peroxidase (one specific for IgG test, the other specific for IgM test) and one microplate only. The principle of the method and the procedure are the same in both the tests. Use reagents for IgG or reagents for IgM depending on the isotype which is under investigation.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Volume d'échantillon

    10 μL

    Durée du test

    2.5 h

    Protocole

    The first study on the anti-phospholipid antibodies began in 1906 when Wasserman introduced a serological test for syphilis. In 1942 it was discovered that the active component is a phospholipid called Cardiolipin. In the 1950's it was observed that a large number of people appeared to be positive for syphilis tests but did not show any evidence of disease. Initially the phenomenon was classified as a series of false positive syphilis tests, before a more accurate analysis revealed, for this group of patients, a high prevalence of autoimmune disorders including SLE and Sjögrens syndrome. The term lupus anticoagulant (LA), used for the first time in 1972, derives from experimental observations in which an increased risk of thrombosis was observed, paradoxically, with the presence of some anticoagulants factors, the term LA is not totally correct, in fact the disease is present more frequently in patients without lupus and it is associated with thrombosis rather than to abnormal bleeding.

    Restrictions

    For Research Use only
  • Stock

    4 °C
  • Antigène Tous les produits Anti-Cardiolipin Antibody (ACA)

    Anti-Cardiolipin Antibody (ACA)

    Autre désignation

    ANTI CARDIOLIPIN

    Classe de substances

    Antibody
Vous êtes ici:
Chat with us!